Antonio
González Martín
Consultor Médico
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valme (5)
2024
2022
-
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Gynecologic Oncology, Vol. 166, Núm. 1, pp. 36-43
-
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study
BMC Cancer, Vol. 22, Núm. 1
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428